EMAIL THIS PAGE TO A FRIEND

Anticancer Research

The multi-tyrosine kinase inhibitor TKI258, alone or in combination with RAD001, is effective for treatment of human leukemia with BCR-ABL translocation in vitro.


PMID 25202073

Abstract

We're sorry this abstract is currently not available.